News

MedFlow Clinical has been recognised as a global top 10 clinical trial supply company by Life Sciences Review. Read the full story...


MedFlow Clinical: Revolutionising Clinical Trial Supply Management

Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has heralded the start of its next successful phase with four promotions and eight new arrivals.


Dr Shailendra Singh, CEO of Cellomatics Biosciences, comments: “Capitalising on our existing strengths and internal team expertise, we intend to further consolidate our position as a specialist biology CRO by broadening and deepening our service offerings in 2024. With these new appointments and internal restructuring, we are poised to catapult ourselves to the next phase of our growth journey.”

Check out the Bristows Biotech Review of the Year. This report reflects on the key developments in the biotech industry, including:



  • Legal updates

  • Generative AI 

  • The Unified Patent Court

  • CRISPR technology 

  • Predictions for 2024


 

Creative Places enters new era with the appointment of new partner and the retirement of co-founder

 

Seb Denby is promoted to Partner as co-founder Jonathan Burroughs retires

 

16th January 2024: Creative Places, a leading R&D real estate advisor, announces the promotion of Seb Denby to Partner and the retirement of its co-founder and former CEO, Jonathan Burroughs.

 

Sandwich, Kent, UK, 17th January 2023 / Sciad Newswire / Discovery Park Ventures (DPV) announces an investment of £100K into Vox Imaging Technology Ltd. (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and customisable instrument is believed to be the first scanning laser ophthalmoscope especially designed for laboratory use, able to produce high-quality data rapidly. Vox Imaging is the eighth investment from DPV’s first fund.

As the life sciences sector continues to evolve at a rapid pace, Biocair, a leading global life science logistics expert, stands at the forefront of industry excellence and customer service. Manish Joshi, Biocair’s Chief Commercial Officer, gives us insight into how Biocair is staying ahead of trends that will shape the industry in 2024.


Sustainability revolutionizing the life sciences supply chain

Enter our competition for a chance to win a place on a concentrated three-day bootcamp in Boston with boardroom-style sessions, led by top life science businesses in the Greater Boston cluster, aimed at providing a focused ‘Getting US-ready’ experience. Whether you are looking to enter the US market for investment, collaborations or clients, this is a brilliant opportunity to embark on a journey to elevate your business to the next level.


See full details, including eligibility and how to enter 

CELLBANKER® freezing media from AMSBIO is now available in customizable formats, seamlessly integrating into cell manufacturing processes with personalized formulations, volumes, and packaging.


Cited in over 500 scientific publications, the CELLBANKER range has proven itself as a safe and reliable solution for storing cells and tissues. This includes GMP-grade, chemically defined formulations specifically designed for the storage of biospecimens for clinical applications.

• Sentiment among UK CFOs has risen for the second consecutive quarter, with optimism running well above average levels;

• Inflation and high interest rates have dropped down the CFO risk list;1

• Corporate risk appetite has risen to an 18-month high but remains subdued relative to its long-term average;

• 63% of CFOs anticipate higher investment in new technology;

• CFOs believe geopolitical factors pose the greatest external risk to their own businesses over the next 12 months.

Pages